Conceptus Essure Contraceptive Could Go To Panel As Early As July
This article was originally published in The Gray Sheet
Executive Summary
Conceptus believes that FDA's Obstetrics and Gynecology Devices Panel could review the company's Essure non-incisional permanent birth control procedure PMA as early as July or October